Advertisement

Lung Cancer pp 186-206 | Cite as

Treatment of Limited-Stage Small Cell Lung Cancer

  • Ritsuko Komaki
Part of the M.D. Anderson Cancer Care Series book series (MDCCS)

Keywords

Clin Oncol Small Cell Lung Cancer Radiat Oncol Biol Phys Concurrent Chemotherapy Central Nervous System Metastasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Readings

  1. Aisner SC, Finkelstein DM, Ettinger DS, et al. The clinical significance of variantmorphology small-cell carcinoma of the lung. J Clin Oncol 1990;8:402–408.PubMedGoogle Scholar
  2. Ariyoshi Y, Fukuoka M, Furuse K, et al. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group. Jpn J Clin Oncol 1994;24:275–281.PubMedGoogle Scholar
  3. Arriagada R, Le Chevalier T, Pignon JP, et al. Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer. N Engl J Med 1993;329:1848–1852.CrossRefPubMedGoogle Scholar
  4. Arriagada R, Le Chevalier T, Ruffie P, et al. Alternating radiotherapy and chemotherapy in 173 consecutive patients with limited small cell lung carcinoma. GROP and the French Cancer Center’s Lung Group. Int J Radiat Oncol Biol Phys 1990;19:1135–1138.PubMedGoogle Scholar
  5. Arriagada R, Pellae-Cosset B, Cueto Ladron de Guevara JC, et al. Alternating radiotherapy and chemotherapy schedules in limited small cell lung cancer: analysis of local chest recurrences. Radiother Oncol 1991;20:91–98.CrossRefPubMedGoogle Scholar
  6. Auperin A, Arriagada R, Pignon JP, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999;341:476–484.CrossRefPubMedGoogle Scholar
  7. Bunn PA, Ihde DC. Small cell bronchogenic carcinoma: a review of therapeutic results. In: Livingston RB, ed. Lung Cancer. Vol 1. Boston, Mass: Nijhoff; 1981:169–208.Google Scholar
  8. Carney DN. Lung cancer biology. Semin Radiat Oncol 1995;5:4–10.PubMedGoogle Scholar
  9. Choi NC, Herndon JE II, Rosenman J, et al. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer. J Clin Oncol 1998;6:3528–3536.Google Scholar
  10. Cox JD. Dose-response in small cell carcinoma [editorial]. Int J Radiat Oncol Biol Phys 1988;14:393–394.PubMedGoogle Scholar
  11. Cox JD, Komaki R, Byhardt RW, et al. Results of whole-brain irradiation for metastases from small cell carcinoma of the lung. Cancer Treatment Reports 1980;64:957–961.PubMedGoogle Scholar
  12. Coy P, Hodson I, Payne DG, et al. The effect of dose of thoracic irradiation on recurrence in patients with limited stage small cell lung cancer. Initial results of a Canadian Multicenter randomized trial. Int J Radiat Oncol Biol Phys 1988;14:219–226.PubMedGoogle Scholar
  13. Cull A, Gregor A, Hopwood P, et al. Neurological and cognitive impairment in long-term survivors of small cell lung cancer [abstract]. Eur J Cancer 1994;30A(8):1067–1074.CrossRefPubMedGoogle Scholar
  14. Ettinger DS, Seiferheld WF, Abrams RA, et al. Cisplatin (P), etoposide (E), paclitaxel (T), and concurrent hyperfractionated thoracic radiotherapy (TRT) for patients (Pts) with limited disease (LD) small cell lung cancer (SCLC): preliminary results of RTOG 96-09 [abstract]. Proc Am Soc Clin Oncol 2000;19:490a.Google Scholar
  15. Feld R, Ginsberg RJ, Payne DG. Treatment of small cell lung cancer. In: Roth JA, Ruckdeschel JC, Weisenburger TH, eds. Thoracic Oncology. Philadelphia, PA: Saunders; 1993:229–262.Google Scholar
  16. Fox W, Scadding JG. Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up. Lancet 1973;2(7820):63–65.CrossRefPubMedGoogle Scholar
  17. Glisson B, Scott C, Komaki R, et al. Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: results of Radiation Therapy Oncology Group trial 93-12. J Clin Oncol 2000;18:2990–2995.PubMedGoogle Scholar
  18. Goto K, Nishiwaki Y, Takada M, et al. Final results of a phase III study of concurrent versus sequential thoracic radiotherapy (TRT) in combination with cisplatin (P) and etoposide (E) for limited-stage small cell lung cancer (LD-SCLC): the Japan Clinical Oncology Group (JCOG) study [abstract]. Proc Am Soc Clin Oncol 1999;18:A1805. Abstract 468a.Google Scholar
  19. Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer statistics, 2001. CA Cancer J Clin 2001;51:15–36.PubMedCrossRefGoogle Scholar
  20. Hainsworth JD, Gray JR, Stroup SL, et al. Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities. J Clin Oncol 1997;15:3464–3470.PubMedGoogle Scholar
  21. Janaki L, Rector D, Turrisi A, et al. Patterns of failure and second malignancies from SWOG-8629: concurrent cisplatin, etoposide, vincristine, and once daily radiotherapy for the treatment of limited small cell lung cancer [abstract]. Proc Am Soc Clin Oncol 1994;13:331.Google Scholar
  22. Johnson RE, Brereton HD, Kent CH. Small-cell carcinoma of the lung: attempt to remedy causes of past therapeutic failure. Lancet 1976;2(7980):289–291.CrossRefPubMedGoogle Scholar
  23. Johnson BE, Bridges JD, Sobczeck M, et al. Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine. J Clin Oncol 1996;14:806–813.PubMedGoogle Scholar
  24. Johnson BE, Salem C, Nesbitt J, et al. Limited stage small cell lung cancer treated with concurrent hyperfractionated chest radiotherapy and etoposide/cisplatin. Lung Cancer 1993;9(suppl 1):S21–S26.CrossRefGoogle Scholar
  25. Kies MS, Mira JG, Crowley JJ, et al. Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a Southwest Oncology Group study. J Clin Oncol 1987;5:592–600.PubMedGoogle Scholar
  26. Komaki R, Byhardt RW, Anderson T, et al. What is the lowest effective biologic dose for prophylactic cranial irradiation? Am J Clin Oncol 1985;8:523–527.PubMedGoogle Scholar
  27. Komaki R, Cox JD, Whitson W. Risk of brain metastasis from small cell carcinoma of the lung related to length of survival and prophylactic irradiation. Cancer Treatment Reports 1981;65:811–814.PubMedGoogle Scholar
  28. Komaki R, Meyers CA, Shin DM, et al. Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys 1995a;33:179–182.CrossRefPubMedGoogle Scholar
  29. Komaki R, Milas L, Glisson B, et al. Effect of duration of thoracic radiation therapy (TRT) on the outcome of patients with limited small cell lung cancer (LSCLC) treated with chemotherapy and radiation therapy [abstract]. Radiother Oncol 2000;56:S57.Google Scholar
  30. Komaki R, Shin DM, Glisson BS, et al. Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer. Int J Radiat Oncol Biol Phys 1995b;31:807–811.CrossRefPubMedGoogle Scholar
  31. Liengswangwong V, Bonner JA, Shaw EG, et al. Limited-stage small-cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapy. J Clin Oncol 1994;12:496–502.PubMedGoogle Scholar
  32. Looney WB. The experimental basis of new strategies in combining chemotherapy and radiotherapy. In: Horwich A, ed. Combined Radiotherapy and Chemotherapy in Clinical Oncology. London: Edward Arnold; 1992:23–33.Google Scholar
  33. McCracken JD, Janaki LM, Crowley JJ, et al. Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group study. J Clin Oncol 1990;8:892–898.PubMedGoogle Scholar
  34. Murray N, Coy P, Pater JL, et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1993;11:336–344.PubMedGoogle Scholar
  35. National Comprehensive Cancer Network. Oncology Practice Guidelines. Small cell lung cancer. Oncology (suppl) 1996;10:179–194.Google Scholar
  36. Noda K, Nishiwaki Y, Kawahara M, et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 2002;346:85–91.CrossRefPubMedGoogle Scholar
  37. Nugent JL, Bunn PA Jr, Matthews MJ, et al. CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival. Cancer 1979;44:1885–1893.PubMedGoogle Scholar
  38. Pieterman RM, van Putten JW, Meuzelaar JJ, et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 2000;343:254–261.CrossRefPubMedGoogle Scholar
  39. Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 1992;327:1618–1624.PubMedCrossRefGoogle Scholar
  40. Shaw E, Su J, Eagan R, et al. Analysis of long-term survival and impact of prophylactic cranial irradiation in complete responders with small cell lung cancer: analysis of the Mayo Clinic and North Central Cancer Treatment Group data bases. Proc Am Soc Clin Oncol 1993;12:328.Google Scholar
  41. Siu LL, Shepherd FA, Murray N, et al. Influence of age on the treatment of limited-stage small-cell lung cancer. J Clin Oncol 1996;14:821–828.PubMedGoogle Scholar
  42. Stahel RA, Weber E. Small cell lung cancer: the new biology. Semin Radiat Oncol 1995;5:11–18.PubMedGoogle Scholar
  43. Turrisi AT, Glover DJ, Mason B, et al. Long-term results of platinum, etoposide and twice daily thoracic radiotherapy for limited small cell lung cancer: results on 32 patients with 48 month minimum follow-up [abstract]. Proc Am Soc Clin Oncol 1992;11:292.Google Scholar
  44. Turrisi AT III, Kim K, Blum R, et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 1999;340:265–271.CrossRefPubMedGoogle Scholar
  45. Wagner H, Kim K, Johnson DH, et al. Daily vs. twice-daily thoracic irradiation with concurrent cisplatin/etoposide chemotherapy as initial therapy for patients with limited small cell lung cancer: preliminary results of a phase III prospective intergroup trial. Int J Radiat Oncol Biol Phys 1994;30(suppl 1):178.Google Scholar
  46. Warde P, Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 1992;10:890–895.PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 2003

Authors and Affiliations

  • Ritsuko Komaki

There are no affiliations available

Personalised recommendations